Lakeshore Biopharma Co revenue was $614.96M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, LSB annual revenue was $615.0M, with 7.2% growth year-over-year.
LSB past revenue growth
How has LSB's revenue growth performed historically?
Lakeshore Biopharma Co (NASDAQ: LSB) reported Q1 2025 revenue of N/A up N/A year over year. In the same quarter last year, Lakeshore Biopharma Co's revenue was $135.35 million.
What was Lakeshore Biopharma Co's revenue in 2025?
Lakeshore Biopharma Co's annual revenue for the twelve months ending Mar 31, 2025 was $614.96 million, a 7.24% increase year over year.
How much does Lakeshore Biopharma Co make in a day?
Based on Lakeshore Biopharma Co annual revenue for the past four years, LSB makes an average of $1,629,130.69 per day.
What was Lakeshore Biopharma Co's annual revenue growth in the past year?
As of Q3 2025, Lakeshore Biopharma Co's revenue has grown 7.24% year over year. This is 138.15 percentage points lower than the US Biotechnology industry revenue growth rate of 145.39%. Lakeshore Biopharma Co's revenue in the past year totaled $614.96 million.
How much does Lakeshore Biopharma Co make in a year?
Lakeshore Biopharma Co's revenue by year for the past four years is:
Lakeshore Biopharma Co's revenue for the twelve months ending Mar 31, 2025 was $614.96 million, a 7.24% increase year over year.
Lakeshore Biopharma Co's annual revenue for Mar 31, 2024 was $573.42 million, a 16.56% decrease from 2023.
Lakeshore Biopharma Co's annual revenue for 2023 was $687.20 million, a 36.63% increase from 2022.
Lakeshore Biopharma Co's annual revenue for 2022 was $502.95 million, a 95.69% increase from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.